Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Oragenics, Inc. (OGEN) had Return on Equity of -35.61% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.20M |
|
-- |
|
-- |
|
$2.26M |
|
$-2.26M |
|
$0.03M |
|
$-2.22M |
|
$-2.22M |
|
$-2.20M |
|
$-2.20M |
|
$-2.20M |
|
$-2.20M |
|
$-2.26M |
|
$-2.26M |
|
4.30M |
|
4.30M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$7.49M |
|
-- |
|
-- |
|
$7.49M |
|
$1.31M |
|
-- |
|
-- |
|
$1.31M |
|
$6.18M |
|
$6.18M |
|
$6.18M |
|
4.38M |
|
| Cash Flow Statement Financials | |
$-2.20M |
|
$4.00M |
|
$-0.09M |
|
$4.40M |
|
$6.11M |
|
$1.71M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.73 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-35.61% |
-35.61% |
|
-29.39% |
|
-35.61% |
|
$1.41 |
|
$-0.51 |
|
$-0.51 |
|